Vectorite Biomedical Inc. (4170.TWO) Key Statistics
$12.00TWO: 4170.TWOMarket Cap $525.26M
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Vectorite Biomedical Inc. (4170.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
4.46
P/B ratioShare price divided by book value per share.
1.03
P/S ratioMarket value divided by annual revenue.
9.58
PEG ratioP/E divided by the earnings growth rate.
0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-22.79
EV / RevenueEnterprise value against annual revenue.
6.72
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
22.42%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
31.09%
Operating marginRevenue left after operating costs.
-31.82%
Net marginRevenue left after every cost, including tax and interest.
215.70%
Return on equityProfit as a percentage of shareholders’ equity.
26.13%
Return on assetsProfit as a percentage of total assets.
-3.03%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
10.05
Quick ratioThe same, excluding inventory.
9.08
Debt to equityTotal borrowings against shareholders’ equity.
0.00
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$2.69
Book value per shareShareholders’ equity divided by shares outstanding.
$11.67
Shares outstandingShares currently issued.
43,771,370
Market capitalisationShare price times shares outstanding.
$525.26M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
43
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Vectorite Biomedical Inc. (4170.TWO) statistics — frequently asked questions
What is Vectorite Biomedical Inc.'s P/E ratio?
Vectorite Biomedical Inc. (4170.TWO) trades on a price-to-earnings ratio of 4.46.
What is Vectorite Biomedical Inc.'s return on equity?
Vectorite Biomedical Inc. (4170.TWO) reports a return on equity of 26.13%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Vectorite Biomedical Inc. carry?
Vectorite Biomedical Inc. (4170.TWO) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
What is Vectorite Biomedical Inc.'s profit margin?
Vectorite Biomedical Inc. (4170.TWO) keeps 215.70% of revenue as net profit after every cost, including tax and interest.